Article · 5 Oct 2026
Conference abstract
Differences in Bioavailabilities (BA) determined using pharmacokinetic and pharmacodynamic parameters of endogenous compounds
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
B A may be determined using both plasma concentrations of a drug and its pharmacological eff ects. However, resulting BA can be substantially diff erent as shown in this inhalation insulin study. In a randomized crossover study, 30 healthy subjects (30?1 years) received 10 IU Actrapid ? subcutaneously and 187 IU (6.5 mg) of recombinant human insulin powder by inhalation using the Cyclohaler TM dry powder inhaler under euglycemic glucose clamp conditions. Relative BA following the inhalation administration compared with the subcutaneous dose were 12.0?1.8% and 6.3?0.6% when determined using baseline-adjusted insulin and glucose infusion rate (GIR), respectively. To explain diff erences in BA, a pharmacokinetic- pharmacodynamic model was developed and BAs were predicted at diff erent doses of inhalation insulin with the fi xed 10 IU subcutaneous dose. BA predicted using 3.25 mg inhaled insulin and GIR were 12% and 7.5%, respectively. Without baseline adjustment BA determined with insulin and GIR were similar (11% and 9.0%, respectively). However, a hysteresis plot of GIR vs corresponding insulin concentration showed more potent GIR responses for the same plasma concentrations of insulin following the subcutaneous dose, although the potency of insulin in Actrapid ? and the inhalation powder formulations was the same. Th us, there may be some diff erences in the delivery of insulin to the target site following SC and inhalation administration. In conclusion, the diff erence in BA of insulin and glucose could be explained in part by the non- linear pharmacokinetic-pharmacodynamic relationship. However, there may be other contributing factors (baseline adjustment, diff erent delivery to active site) as well
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chyung S. Cook”